Article Information
History
- July 10, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Louisa Ruhl1,
- Isabell Pink2,
- Jenny F. Kühne1,
- Kerstin Beushausen1,
- Jana Keil1,
- Stella Christoph1,
- Andrea Sauer2,
- Lennart Boblitz2,
- Julius Schmidt2,
- Sascha David3,
- Hans-Martin Jäck4,
- Edith Roth4,
- Markus Cornberg5,6,
- Thomas F. Schulz7,9,10,
- Tobias Welte2,8,
- Marius M. Höper2,8 and
- Christine S. Falk1,8,9,*
- 1Institute of Transplant Immunology, MHH, D
- 2Department of Pneumology, MHH, D
- 3Department of Intensive Care Medicine, University of Zurich, CH
- 4Division of Molecular Immunology, Internal Medicine III, Nikolaus-Fiebiger-Center of Molecular Medicine, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, D
- 5Department of Gastroenterology Hepatology and Endocrinology, MHH, D
- 6Center for Individualized Infection Medicine CiiM
- 7Institute of Virology, MHH, D
- 8German Center for Lung Diseases DZL/BREATH
- 9German Center for Infection Research, DZIF, TTU-IICH
- 10Excellence Cluster 2155 RESIST, MHH
- ↵*Corresponding author:
Christine S. Falk, PhD., Institute of Transplant Immunology, Hannover Medical School, MHH, Carl-Neuberg Str. 1, 30625 Hannover, Germany, Phone: +49 511 532 9745, Fax: +49 511 532 8090, e-Mail: falk.christine{at}mh-hannover.de
Posted July 10, 2021.
Endothelial dysfunction determines severe COVID-19 in combination with dysregulated lymphocyte responses and cytokine networks
